AI English summary of an SEC filing — figures as filed
Quest Diagnostics DGXThe company said net revenues for Q3 2024 (3 months) rose to $2,488 million, up 8.5% from $2,295 million in Q3 2023. It said that revenue growth included organic growth of 4.2%.
Key points
AI summaryThe company said net revenues for Q3 2024 (3 months) rose to $2,488 million, up 8.5% from $2,295 million in Q3 2023. It said that revenue growth included organic growth of 4.2%.
The company said operating income for Q3 2024 fell 3.3% to $330 million, or 13.3% of net revenues. Adjusted operating income rose 1.3% to $385 million, or 15.5% of net revenues.
The company said reported diluted EPS for Q3 2024 rose 1.5% to $1.99, and adjusted diluted EPS rose 3.6% to $2.30. Net income attributable to Quest Diagnostics for the same quarter was $226 million.
The company set its full-year 2024 net revenue guidance at $9.80 billion to $9.85 billion, versus prior guidance of $9.50 billion to $9.58 billion. Adjusted diluted EPS guidance is $8.85 to $8.95.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Quest Diagnostics Q3 Net Revenues Reach $2,488 million, Up 8.5%
The company said net revenues for Q3 2024 (3 months) rose to $2,488 million, up 8.5% from $2,295 million in Q3 2023. It said that revenue growth included organic growth of 4.2%.
Source · Based on the filing body and exhibits
Q3 Operating Income of $330 million and Adjusted Operating Income of $385 million
The company said operating income for Q3 2024 fell 3.3% to $330 million, or 13.3% of net revenues. Adjusted operating income rose 1.3% to $385 million, or 15.5% of net revenues.
Source · Based on the filing body and exhibits
Q3 Diluted EPS of $1.99, Adjusted $2.30
The company said reported diluted EPS for Q3 2024 rose 1.5% to $1.99, and adjusted diluted EPS rose 3.6% to $2.30. Net income attributable to Quest Diagnostics for the same quarter was $226 million.
Source · Based on the filing body and exhibits
Updated Full-Year Outlook: Net Revenues of $9.80 to $9.85 billion
The company set its full-year 2024 net revenue guidance at $9.80 billion to $9.85 billion, versus prior guidance of $9.50 billion to $9.58 billion. Adjusted diluted EPS guidance is $8.85 to $8.95.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…